Use of a double entry database to follow up ureteric stent use and evaluate wait times to definitive ureteroscopy in obstructing urolithiasis
BAUS ePoster online library. Green H. Jun 25, 2019; 259481; P11-7 Disclosure(s): I have no disclosures
Dr. Hamish Green
Dr. Hamish Green
Login now to access Regular content available to all registered users.

You may also access this content "anytime, anywhere" with the Free MULTILEARNING App for iOS and Android
Abstract
Rate & Comment (0)
Introduction & Objectives:
Ureteric stents are used to relieve ureteric obstruction, facilitate endoscopic management of urolithiasis, reduce intra-operative complications and improve stone-free rates. The risks of loss to follow up are considerable. Stent use increases the risk of post-ureteroscopy sepsis and they cause unpleasant symptoms for patients. The risk of sepsis increases five-fold with stent dwell times longer than 30 days.

We evaluated our follow up rate and wait times to definitive ureteroscopy for obstructing ureteric stones using our double entry database.

METHODS:

An electronic database of all patients who have a ureteric stent inserted is kept along with a separate database which records the use of all stents opened. A retrospective analysis of all patients with ureteric stents inserted from December 2017 to July 2018 was performed.

Results:

140 patients were included. No patients were lost to follow up. 19% had stents placed acutely for obstructing stones with a mean time to definitive ureteroscopy of 58 days (median 43 days). Mean dwell time post-ureteroscopy for patients with urolithiasis who self-removed their stent (n=52) was 4.5 days and 31.8 days for those who required cystoscopic removal (n=17). 10% of patients re-presented to hospital with stent-related pain.

Conclusions:

Our double entry system helps to ensure a 100% follow up rate. The mean time from stent placement to definitive ureteroscopy of 58 days may increase the risk of post-ureteroscopy sepsis. Further research is required to evaluate our rate of infectious complications.
    This eLearning portal is powered by:
    This eLearning portal is powered by MULTIEPORTAL
Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.


Save Settings